Pomelo Care Secures $92M to Expand Beyond Maternity Healthcare

With participation from prominent investors including Andreessen Horowitz and Atomico, Pomelo plans to leverage the funding to expand its care models and technologies beyond maternity services, potentially impacting women’s health more broadly.

TCB TeamJan 10, 20264 min

Financing Details

Raised $92 million in Series C funding.
Led by Stripes with Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, SV Angel participation.

Strategic Growth

Expansion plans beyond initial focus on maternity care.
Potential to address wider women’s health and family care needs.

Industry Significance

Reflects investor confidence in digital and personalized healthcare models.
Aligns with broader trends to support maternal and women’s health innovations.

Source: Pomelo Care Series C - MedCity News

The Catalyst Brief

Independent biotech intelligence, every week.

Get curated biotech intelligence across AI, industry, innovation, investment, medtech, and policy delivered to your inbox.

Keep reading

Aug 29, 2026

AusperBio Raises $120 Million Series C To Push AHB-137 Through Phase 3 In Chronic Hepatitis B

Sophia Reynolds

Aug 28, 2026

Genentech Pays $45 Million Upfront For DualityBio ADCs, Targeting Post-Topoisomerase Resistance

Dr. Alex Morgan

Aug 27, 2026

JATT III Acquisition Raises $60 Million In Nasdaq IPO, Reopening A Biotech SPAC Playbook As Traditional Listings Recover

Dr. Alex Morgan

Aug 26, 2026

Biohaven Licenses Kv7 Epilepsy Platform To SK Biopharmaceutical For Up To $795 Million, Bolstering Cash Ahead Of Readouts

Dr. Priya Nandakumar

All Healthcare Investment